Giovanni Carlo Miceli

Dr. Giovanni Carlo Miceli

University of Palermo, Palermo, Sicilia, Italy
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2022 in Polymers
Verified
Journal Article
Open access
PDF file
Giovanni Carlo MiceliGiovanni Carlo Miceli
Giovanni Carlo Miceli
FPFabio Salvatore Palumbo
Fabio Salvatore Palumbo
FBFrancesco Paolo Bonomo
Francesco Paolo Bonomo
MZMassimiliano Zingales
Massimiliano Zingales
MLMariano LICCIARDI
Mariano LICCIARDI
A microfibrous tubular scaffold has been designed and fabricated by electrospinning using poly (1,4-butylene succinate) as biocompatible and biodegradable material. The scaffold morphology was optimized as a small diameter and micro-porous conduit, able to foster cell integration, adhesion, and growth while avoiding cell infiltration through the graft’s wall. Scaffold morphology and mechanical properties were explored and compared to those of native conduits. Scaffolds were then seeded with adult normal human dermal fibroblasts to evaluate cytocompatibility in vitro. Haemolytic effect was evaluated upon incubation with diluted whole blood. The scaffold showed no delamination, and mechanical properties were in the physiological range for tubular conduits: elastic modulus (17.5 ± 1.6 MPa), ultimate tensile stress (3.95 ± 0.17 MPa), strain to failure (57 ± 4.5%) and suture retention force (2.65 ± 0.32 N). The shown degradation profile allows the graft to provide initial mechanical support and functionality while being colonized and then replaced by the host cells. This combination of features might represent a step toward future research on PBS as a biomaterial to produce scaffolds that provide structure and function over time and support host cell remodelling.

18 September 2023 in ACS Applied Polymer Materials
Verified
Journal Article
Open access
Giovanni Carlo MiceliGiovanni Carlo Miceli
Giovanni Carlo Miceli
AMAnnalisa Martorana
Annalisa Martorana
FCFrancesco Cancilla
Francesco Cancilla
GPGiovanna Pitarresi
Giovanna Pitarresi
MLMariano LICCIARDI
Mariano LICCIARDI
FPFabio Salvatore Palumbo
Fabio Salvatore Palumbo

Verified
Journal Article
Open access
PDF file
GVGiulio Edoardo Vigni
Giulio Edoardo Vigni
GCGiovanni Cassata
Giovanni Cassata
GCGiusj Caldarella
Giusj Caldarella
RCRoberta Cirincione
Roberta Cirincione
MLMariano LICCIARDI
Mariano LICCIARDI
LCLuca Cicero
Luca Cicero
The treatment of extensive bone loss represents a great challenge for orthopaedic and reconstructive surgery. Most of the time, those treatments consist of multiple-stage surgeries over a prolonged period, pose significant infectious risks and carry the possibility of rejection. In this study, we investigated if the use of a polybutylene succinate (PBS) micro-fibrillar scaffold may improve bone regeneration in these procedures. In an in vivo rabbit model, the healing of two calvarial bone defects was studied. One defect was left to heal spontaneously while the other was treated with a PBS scaffold. Computed tomography (CT) scans, histological and immunohistochemical analyses were performed at 4, 12 and 24 weeks. CT examination showed a significantly larger area of mineralised tissue in the treated defect. Histological examination confirmed a greater presence of active osteoblasts and mineralised tissue in the scaffold-treated defect, with no evidence of inflammatory infiltrates around it. Immunohistochemical analysis was positive for CD56 at the transition point between healthy bone and the fracture zone. This study demonstrates that the use of a PBS microfibrillar scaffold in critical bone defects on a rabbit model is a potentially effective technique to improve bone regeneration.

13 April 2025 in Advanced NanoBiomed Research
Verified
Journal Article
Open access
JKJoshua Killilea
Joshua Killilea
ALAaron Lee
Aaron Lee
ECEstelle A. Cuttaz
Estelle A. Cuttaz
Giovanni Carlo MiceliGiovanni Carlo Miceli
Giovanni Carlo Miceli
LSLeire L. Suquia
Leire L. Suquia
Rylie A.  GreenRylie A. Green
Rylie A. Green
Conductive polymers, such as poly(3,4‐ethyelenedioxythiophene):polystyrene sulfonate (PEDOT:PSS), offer exciting prospects in organic bioelectronic applications. Translation of commercially available formulations of PEDOT:PSS is hampered by leachable contaminants. Herein, a facile processing technique utilizing differences in polymer–solvent affinity and centrifugation of poor dispersions of PEDOT:PSS to remove leachable components is presented. 1H‐nuclear magnetic resonance spectroscopy of the centrifugation supernatant identifies PSS as the most abundant impurity removed. To demonstrate versatility and applicability to bioelectronic applications, centrifuged PEDOT:PSS is blended with medical grade polyurethane. Bulk composite swelling and degradation are largely unaltered, and the electrochemical performance of the composite is not significantly compromised. Marked improvement in cytocompatibility is only observed in composites fabricated using centrifugation, indicating that soluble components such as PSS contribute significantly to cytotoxicity. Removal of excess PSS improves the ability of these polymer systems to act as drug delivery vehicles as evidenced by differences in chemotherapeutic efficacy of doxorubicin following electrophoretic release. It is demonstrated that excess PSS in commercial formulations can exert significant cytotoxicity, and its reduction can produce cytocompatible PEDOT:PSS materials for use across a wide spectrum of bioelectronic applications.

2 February 2026 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Open access
ISImanthi Silva
Imanthi Silva
NKNour Khalil
Nour Khalil
CFChun Lun Frank Fan
Chun Lun Frank Fan
YWYidian Emma Wang
Yidian Emma Wang
BLBecky Leveridge
Becky Leveridge
PBPiers R. Boshier
Piers R. Boshier
The peritoneum, a membranous structure that lines the abdominal cavity, is one of the most common sites to which gastric, colorectal and ovarian cancer metastasise. The presence of peritoneal metastasis is associated with poor prognosis primarily due to the ineffectiveness of systemic therapies against this condition. Direct delivery of chemotherapy to the peritoneal cavity has been proposed as an alternative treatment, although its efficacy is limited by low drug retention. Hydrogel-based delivery solutions have the potential to augment the capabilities of intraperitoneal administration by facilitating sustained therapeutic drug concentrations via extended release. This systematic review provides a comprehensive overview of 39 preclinical studies that show improvements in therapeutic efficacy over carrier-free delivery. Synthetic hydrogels were generally favoured over hydrogels prepared from biomolecules and were largely used to administer small molecule anti-neoplastic agents over immunotherapies. An IDEAL framework analysis highlighted that whilst there is growing research interest, there has been limited clinical translation. Based on a critical analysis of the existing literature, this review offers recommendations and guidelines towards the translation of hydrogel-based drug delivery systems for the treatment of peritoneal metastasis.